For Immediate Release
Chicago, IL – February 8, 2021 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple Inc. AAPL, FedEx Corporation FDX, Ford Motor Company F, Hologic Inc. HOLX and Weyerhaeuser Company WY.
Here are highlights from Friday’s Analyst Blog:
5 Top-Ranked Growth Stocks to Tap February’s Market Rally
Wall Street has resumed its northbound journey after last week’s disappointing performance that was incidentally the worst since October 2020. The primary reason for last week’s extreme volatility — a typical trading practice in which a few key heavily shorted stocks by hedge fund giants were favored by a group of individual investors organized via Reddit’s wallstreetbets forum — has evaporated. Moreover, a series of good economic data and news boosted investors’ confidence.
At this stage, it will be prudent to invest in growth stocks with a favorable Zacks Rank. Notably, growth investors are primarily focused on stocks with aggressive earnings or revenue growth, which should propel their stock price higher in the future. Higher fiscal stimulus and vaccination process are likely to drive the overall growth of the economy.
Wall Street Resumes Northbound Journey
All the three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — gained in each of the first four trading days of this week barring a marginal loss of Nasdaq on Feb 3. On Feb 4, the S&P 500 and the Nasdaq Composite recorded their all-time highs at 3,872.42 and 13,778.42, respectively. The Dow is just 0.7% away from its all-time high of 31,272.22 recorded on Jan 21.
Positive Economic Data and News
First, on Feb 1, the Congressional Budget Office projected that the U.S. economy will expand 4.6% in 2021 after contracting 3.5% last year. The economy is expected to reach the pre-pandemic level of February 2020 by mid-2021, much earlier than what was projected in July. In its latest projection, the Atlanta Fed estimated that the U.S. GDP will grow 6% in first-quarter 2021.
Second, we are in the middle of the fourth-quarter 2020 earnings season, which has so far delivered better-than-expected results. As of Feb 3, total earnings of 223 S&P 500 companies were up 2.5% from the same period last year on 1.5% higher revenues.
Overall, the fourth-quarter earnings for the S&P 500 Index are projected to be up 0.4% year over year on 2% higher revenues. This is in contrast to the projection of a 7.8% decline in earnings on 0.3% higher revenues at the beginning of the reporting cycle.
Third, the Democrats are moving forward with President Joe Biden’s proposed $1.9 trillion Covid-19 relief package. The proposed plan will include increasing direct payments to $2,000 from the existing $600 and supplemental unemployment benefits to $400 per week through September. The proposal also mentions that the minimum wage rate would be hiked to $15 per hour and moratoriums on eviction and foreclosure on mortgages would be extended to Sep 30.
Fourth, per the COVID Tracking Project, daily average new cases in the United States averaged 136,438 in the past week, down 30% from the average two weeks ago. As of Feb 3, there were 91,440 COVID-19 patients in U.S. hospitals on, down from 92,880 a day earlier and the lowest since Nov 27.
Fifth, initial jobless claims totaled 779,000 for the week ended Jan 30, lower than the consensus estimate of 837,000. Previous week’s data was revised downward from 847,000 to 812,000. Initial claims fell for the third straight week and the latest data was the lowest since Nov 28.
The manufacturing purchasing managers’ index of the Institute of Supply Management has expanded for the last eight months. The U.S. manufacturing industry witnessed a V-shaped recovery during the pandemic. Construction spending grew 1% in December. Total vehicle sales increase to 16.6 million units in January from 16.2 million units in December. Factory orders for manufactured goods rose 1.1% in December.
Our Top Picks
We have narrowed down our search to five large-cap (market capital > $10 billion) stocks as these companies have an established business model and a solid brand value. These stocks have strong growth potential for 2021 and witnessed robust earnings estimate revisions in the last 7 to 60 days. Each of our picks carries a Zacks Rank #1 (Strong Buy) and has a Growth Score A. You can see the complete list of today’s Zacks #1 Rank stocks here.
Apple’s Services and Wearables businesses are expected to drive top-line growth in fiscal 2021 and beyond. Although its business primarily runs around its flagship iPhone, the Services portfolio has emerged as the new cash cow. The company’s focus on autonomous vehicles and augmented reality/virtual reality technologies presents growth opportunities in the long haul.
The company has an expected earnings growth rate of 36.3% for the current year (ending September 2021). The Zacks Consensus Estimate for the current year has improved 10.9% over the last 7 days.
FedEx is the leader in global express delivery services. It provides a broad portfolio of transportation, e-commerce and business services through companies competing collectively, operating independently and managed collaboratively, under the FedEx brand.
The company has an expected earnings growth rate of 81.5% for the current year (ending May 2021). The Zacks Consensus Estimate for current-year earnings has improved 12% over the last 60 days.
Ford designs, manufactures, markets, and services a range of Ford cars, trucks, sport utility vehicles, electrified vehicles, and Lincoln luxury vehicles worldwide. It operates through three segments: Automotive, Mobility, and Ford Credit.
The company has an expected earnings growth rate of more than 100% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 12.5% over the last 30 days.
Hologic develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women’s health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health.
The company has an expected earnings growth rate of more than 100% for the current year (ending September 2021). The Zacks Consensus Estimate for current-year earnings has improved 15.6% over the last 7 days.
Weyerhaeuser is one of the leading U.S. forest product companies with operations primarily concentrated in Southern California, Nevada, Washington, Texas, Maryland and Virginia. It caters to a diverse clientele spread over the United States, Canada, Japan, Europe and other regions. The company has an expected earnings growth rate of 24.8% for the current year. The Zacks Consensus Estimate for current-year earnings has improved 7.3% over the last 7 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ford Motor Company (F) : Free Stock Analysis Report
Weyerhaeuser Company (WY) : Free Stock Analysis Report
Hologic, Inc. (HOLX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
